A new drug from California-based pharma company Amgen, which has concluded a phase II trial, shows promise as a powerful ...

“Our findings show liraglutide may be effective for treating stubborn, high-frequency migraines in patients with obesity, and that this effect is independent of weight loss,” the researchers concluded ...

Eli Lilly's experimental obesity therapy bimagrumab drew mixed reactions from Wall Street after the company recently ...

Researchers found that once-monthly maridebart cafraglutide led to substantial weight loss and improved glycemic control in ...